| Interactions between Xenobiotics and DME (XEOTIC)
|
| Amino Acid(s), Peptide(s) or Protein(s) |
| Peptide |
Click to Show/Hide the Full List of Xenobiotics: 55 Xenobiotics
|
| Adenoregulin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02136
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Adenoregulin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 125 ug/ml) |
[1] |
| Androctonin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02224
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Androctonin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[2] |
| Anopheles cecropin-A amidated isoform |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02230
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Anopheles cecropin-A amidated isoform inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 5-10 microM) |
[3], [4] |
| Antifungal protein Pf-AFP1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02252
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Antifungal protein Pf-AFP1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[5] |
| Antifungal protein Pr-2 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02255
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Antifungal protein Pr-2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[6] |
| Antimicrobial peptide HP(2-20) |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02283
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Antimicrobial peptide HP(2-20) inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) |
[7] |
| Arachnid gomesin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03497
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Arachnid gomesin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 1.6-3.15 microM) |
[8] |
| ARD1 Mutant ETD130 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03327
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD130 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD131 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03328
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD131 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD132 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03329
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD132 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD133 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03330
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD133 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD134 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03331
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD134 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD135 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03332
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD135 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD140 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03333
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD140 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD150 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03334
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD150 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD151 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03335
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD151 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD152 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03336
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD152 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD154 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03337
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD154 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD156 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03338
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD156 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| ARD1 Mutant ETD179 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03339
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
ARD1 Mutant ETD179 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[9] |
| Cecropin1 peptide derivative Px-cec1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04767
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Cecropin1 peptide derivative Px-cec1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 16.0 ug/ml) |
[10] |
| Colutellin-A |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02906
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Colutellin-A inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[11] |
| Defensin ARD1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03102
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Defensin ARD1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 12.5 ug/ml) |
[9] |
| Defensin heliomicin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03109
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Defensin heliomicin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 6-12 microM) |
[12], [13] |
| Dermaseptin B1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03158
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Dermaseptin B1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 125 ug/ml) |
[14], [15] |
| Dermaseptin DS1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03151
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Dermaseptin DS1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 100 ug/ml) |
[16], [14] |
| Dermaseptin DS2 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03153
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Dermaseptin DS2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[14] |
| Dermaseptin DS3 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03154
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Dermaseptin DS3 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[14], [17] |
| HP(2-20) analogue Anal 1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02207
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
HP(2-20) analogue Anal 1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) |
[7] |
| HP(2-20) analogue Anal 2 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02208
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
HP(2-20) analogue Anal 2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) |
[7] |
| HP(2-20) analogue Anal 3 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02209
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
HP(2-20) analogue Anal 3 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 25 ug/ml) |
[7] |
| HP(2-20) analogue Anal 4 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02210
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
HP(2-20) analogue Anal 4 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) |
[7] |
| HP(2-20) analogue Anal 5 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02211
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
HP(2-20) analogue Anal 5 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 50 ug/ml) |
[7] |
| HP(2-20) analogue Anal 6 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02212
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
HP(2-20) analogue Anal 6 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50-25 ug/ml) |
[7] |
| HP(2-20) analogue Anal 7 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02213
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
HP(2-20) analogue Anal 7 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50-25 ug/ml) |
[7] |
| hrVS-1-derived peptide CGA47-60 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02803
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
hrVS-1-derived peptide CGA47-60 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50 microM) |
[18] |
| hrVS-1-derived peptide CGA47-70 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02804
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
hrVS-1-derived peptide CGA47-70 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 30 microM) |
[18] |
| Human drosomycin-like defensin DLD |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03597
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Human drosomycin-like defensin DLD inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 6.25 microM) |
[19] |
| Human hepcidin Hepc20 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03598
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Human hepcidin Hepc20 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[20] |
| Human hepcidin Hepc25 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03599
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Human hepcidin Hepc25 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[20] |
| Insect attacin-C |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO02333
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Insect attacin-C inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 200 microM) |
[21] |
| Lactoferricin B |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03776
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Lactoferricin B inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[22] |
| Penaeidin-2d |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04506
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Penaeidin-2d inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 20 microM) |
[23], [24] |
| Penaeidin-3a |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04507
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Penaeidin-3a inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC > 20 microM) |
[25] |
| Phlebotomus duboscqi defensin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04560
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Phlebotomus duboscqi defensin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 12.5-25 microM) |
[26] |
| Piscidin Pis-2 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04613
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Piscidin Pis-2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50-100 microM) |
[27] |
| Px-cec1 peptide |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04766
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Px-cec1 peptide inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 16.0 microM) |
[10] |
| Skin peptide tyrosine-tyrosine |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04950
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Skin peptide tyrosine-tyrosine inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 80 ug/ml) |
[28], [29] |
| Spheniscin-2 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04971
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Spheniscin-2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 3-6 microM) |
[30], [31] |
| Spider gomesin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO03498
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Spider gomesin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 1.6-3.15 microM) |
[8] |
| Stomoxyn |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04995
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Stomoxyn inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 50-100 microM) |
[32], [33] |
| Tritrpticin |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO05179
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Tritrpticin inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 250 ug/ml) |
[34], [35] |
| Trp- and Arg-rich peptide 2 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO04532
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Trp- and Arg-rich peptide 2 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[34] |
| Vasostatin-1 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO05229
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Vasostatin-1 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 5 microM) |
[18] |
| Venom antimicrobial peptide-9 |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO05231
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Peptide |
| DME Modulation |
Venom antimicrobial peptide-9 inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus (MIC = 8.3 microM) |
[36] |
| Pharmaceutical Agent(s) |
| Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Chitosan |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO00621
XEOTIC Info
|
Gene Form |
Protein |
| Classification |
Highest Clinical Status: Phase 1/2 |
| DME Modulation |
Chitosan inhibits the drug-metabolizing activity of Cytochrome P450 monooxygenase 51A (cyp51A) from Aspergillus fumigatus |
[37] |
|
|
|
|
|
|